Skip to main content

Table 3 Time-of-addition experiment of FR3T3

From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs

No Sample Entry inhibition (%) Post-entry inhibition (%) Entry and post-entry inhibition (%)
1 FR3T3 (10 μg/mL) 33.86 ± 2.19 64.04 ± 3.06 83.07 ± 4.00
2 FR3T3 (20 μg/mL) 61.68 ± 0.10 83.86 ± 2.58 93.44 ± 5.29
  1. The experiment was performed in triplicate